Hologic Inc (NASDAQ:HOLX)

38.92
Delayed Data
As of May 25
 +0.20 / +0.52%
Today’s Change
35.10
Today|||52-Week Range
46.80
-8.96%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$10.5B

Company Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following business segments: Breast Health, Diagnostics, Medical Aesthetics, GYN Surgical, and Skeletal Health. The Breast Health segment includes a broad portfolio of breast imaging and related products and accessories, including digital mammography systems, computer-aided detection, for mammography and minimally invasive breast biopsy devices, breast biopsy site markers, and breast biopsy guidance systems. The Diagnostics segment comprises Aptima family of Assays, target capture/nucleic acid extraction techonolgy, transcription-mediated amplification technology, hybridization protection assay and dual kinetic assat technologies, instrumentation, and Invader Chemistry Platform. The Medical Aesthetics segment offers SculpSure; PicoSure, MedLite, and RevLite; and MonaLisa Touch. The GYN Surgical segment encompasses the NovaSure Endometrial Ablation System and the MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment covers the discovery and horizon X-ray bone densitometry system, an ultrasound-based osteoporosis assessment product, and Fluoroscan mini C-arm imaging products. The company was founded by S. David Ellenbogen and Jay A. Stein in 1986 and is headquartered in Marlborough, MA.

Contact Information

Hologic, Inc.
250 Campus Drive
Marlborough Massachusetts 01752
P:(508) 263-2900
Investor Relations:
(858) 410-8588

Employees

Shareholders

Mutual fund holders68.51%
Other institutional33.60%
Individual stakeholders2.88%

Top Executives

Stephen P. MacMillanChairman, President & Chief Executive Officer
Robert W. McMahonChief Financial Officer
Tracy Campbell AccardiVice President-Global Research & Development
Peter J. ValentiPresident-Breast & Skeletal Health Solutions
Thomas A. WestPresident-Diagnostics Solutions Division